Skip to search boxSkip to navigationSkip to main content

Non-linear association of periodontal pathogen antibodies with mortality

  • Damian Sanchez-Torres
    ,
  • Dayro Gutierrez-Bejarano
    ,
  • ,
  • Pilar Guallar-Castillon
    ,
  • Paul Muntner
    ,
  • Martin Laclaustra(corresponding author)
*Corresponding author for this work
  • Centro Nacional de Investigaciones Cardiovasculares Carlos III
    ,
  • ,
  • Universidad Autónoma de Madrid
    ,
  • The University of Alabama at Birmingham
    ,
  • St. Louis University
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 628-636 (9 pages)

Journal (Volume, Issue Number)

International Journal of Cardiology (Volume 187, Issue 1)

Publication milestones

  • Published - 06/05/2015

Publication status

Published - 06/05/2015

ISSN

0167-5273

Publication IDs

  • Scopus: 84929159673
  • PubMed: 25863738

Abstract

Background: Periodontal pathogens are associated with predisposition to chronic diseases and death. Antibody levels against them reflect flora burden, although high levels might indicate a protective response. We studied all-cause and cause specific mortality in relation to antibody levels in a representative US sample. Methods: Adults ≥20 years (n=6993) from the second phase of the Third National Health and Nutrition Examination Survey (NHANES III) were followed for a median of 13.2 years. Serum antibodies against Porphyromonas gingivalis (antiPG) and Actinobacillus actinomycetemcomitans (antiAA) were quantified by ELISA at baseline (1991-1994). Mortality hazard ratios (HRs) were calculated across antibody quartiles using the quartile with highest mortality as reference. Results: Median (25th, 75th percentiles) antiPG was 72 (63, 93) ELISA Units (EU) and median antiAA was 70 (64, 89) EU. After adjustment for potential confounders, mortality was highest for participants with antibodies in the third antiPG quartile (72-92 EU), with lower mortality risk for values not only below but also above this range [HR for the 1st to 4th quartiles: 0.81 (95% CI: 0.65, 1.01), 0.67 (95% CI: 0.55, 0.82), 1.00 (Reference), 0.79 (95% CI: 0.64, 0.97)]. In spline regression models the association had an inverted U-shape and mortality exhibited a peak at 84 EU (67th percentile). Mortality was not associated with antiAA. Conclusions: Mortality was highest for those just above the median antiPG and a reduced risk was present among those with lowor high levels of the antibody. Future studies should confirm this downward trend in upper levels and investigate a potential protective role of immunity against P. gingivalis.

Funding Details

Dr. Laclaustra was supported in part by grants CP08/00112, FIS PI10/ 00021 and FIS PI14/0009 from the Instituto de Salud Carlos III (Spain). Yamilee Hurtado-Roca was supported by Scholarship No. 088-FINCyTBDE-2014 from the Peruvian government.
FundersFunding numbers
Peruvian government
-
ISCIII
088-FINCyTBDE-2014